Interviews with inspiring clinicians, scientists, researchers & geneticists in the field of epilepsy - out every Thursday.
Available on your podcast app & YouTube. **NOT FOR CLINICAL OR PATIENT DECISION MAKING**
For sponsorship opportunities contact us or click here for more information.
Looking for earlier episodes? You’ll find our full archive at torierobinson.com/epilepsy-sparks-insights
Could we diagnose epilepsy before the first seizure, offer surgery earlier, or treat its underlying causes? Prof. José Serratosa explores advances in epilepsy surgery, genetics, precision medicine and prevention.
What’s it like to have/develop an epilepsy when you’re 65+ years? Epileptologist Dr. Manuel Toledo shares the differences and challenges in having an epilepsy at an older age, what the priorities are, how medication effectiveness can vary, and more.
Hear how telemedicine, apps, AI, and machine learning can bring epilepsy expertise to people wherever they live - and why relatively simple technology could make a huge difference to millions of lives. With Dr. Victor Patterson.
What does epilepsy care look like when a clinician has to see more than 60 people in one day? Prof. Mamta Singh shares what high-volume epilepsy care really looks like in New Delhi - from specialist epilepsy clinics to outreach services across rural India.
A deep dive into how combined MEG and high-density EEG can precisely localise seizure source in children with drug-resistant epilepsy, improving surgical decision-making and outcomes! With Christos Papadelis, Ph.D..
MRI scans can miss epilepsy lesions that may be treatable with surgery. Dr. Konrad Wagstyl discusses how his biotech AI tools trained on large MRI datasets are helping detect subtle brain abnormalities and identify surgical candidates earlier.
Psychiatric symptoms are integral to the epilepsies and can shape disease course and quality of life. Dr. Andres M. Kanner explains how depression, anxiety, ADHD, and psychosis influence treatment decisions and outcomes.
Flash-back to our most popular episode! Epileptologist & neurologist Dr. Ángel Aledo-Serrano shares his thoughts regarding the antiseizure medication Levetiracetam/Keppra; its effectiveness and side-effects.
Who benefits from genetic testing in epilepsy, and how should uncertain results be interpreted? Christian Bosselmann discusses genome sequencing, variant interpretation, and why re-analysis over time matters.
Award-winning molecular neuropathologist & PI Katja Kobow explains her research into unraveling the intricate interplay between epigenetic alterations and the development of epilepsy, specifically in the context of the adult post-mitotic brain.